Prosecution Insights
Last updated: July 17, 2026

Mh2 Technology Law Grp

8 pending office actions • 5 clients • 7 examiners • 7 art units • 0 of 8 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Quality Metrics (n=241 apps, methodology: how we score firms)

87.5%
Allowance Rate
n=241
+0.69σ
Allowance Rate (norm)
n=241
4.2
OAs to Allowance
n=175
+0.26σ
OAs to Allow (norm)
n=175
1207 days
Time to Allowance
n=175
+8.0pp
Interview Lift
n=241
42.0%
RCE Rate
n=241
1.5%
Appeal Rate
n=241

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=3 (min 20)
89.3%
§102 Overcome
n=28
83.5%
§103 Overcome
n=133
87.2%
§112 Overcome
n=39

Specialization & Scale

A61K, G06F, H04W
Top CPC Subclasses
18%
Top-3 CPC Share
n=241
0
Practitioners
n=241
Apps / Practitioner
n=241 (min 20)

Portfolio Summary

8
Total Pending OAs
1
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (62%)
3
Easy (38%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (62%)
§112 only1 (12%)
Double-patenting only2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CANELLA, KAREN A 2 62.5% +32.5%
MELLER, MICHAEL V 1 47.2% +29.7%
MUKHOPADHYAY, BHASKAR 1 27.8% +36.3%
SMITH, JENNIFER A 1 61.4% +26.1%
LOVE, TREVOR M 1 43.1% +26.1%
SCHLIENTZ, NATHAN W 1 41.2% -19.1%
KOROTCHKINA, LIOUBOV G 1 27.3% +62.7%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17625440 TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD) KOROTCHKINA, LIOUBOV G 92d overdue
18035224 RAW MATERIAL FOR ANIMAL NUTRITION COMPRISING AN ORGANO-MINERAL COMPLEX CONTAINING DIETARY PHOSPHATE AND A HUMIC SUBSTANCE MUKHOPADHYAY, BHASKAR

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17625440 TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD) KOROTCHKINA, LIOUBOV G 92d overdue
17802274 ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY CANELLA, KAREN A 53d overdue
18044169 OXIDATIVE METHOD FOR PREPARING A FERTILIZING COMPOSITION SMITH, JENNIFER A 33d
18040468 HYDROGEL COMPRISING GLYCEROL AND A CARBOMER FOR TREATING THE RESPIRATORY SYMPTOMS OF COVID-19 DISEASE VIA THE NASAL ROUTE LOVE, TREVOR M 42d
18550728 USE OF A RED ALGA EXTRACT AS NEMATOSTATIC AND/OR NEMATICIDAL AGENT MELLER, MICHAEL V
18333261 ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY CANELLA, KAREN A
18035224 RAW MATERIAL FOR ANIMAL NUTRITION COMPRISING AN ORGANO-MINERAL COMPLEX CONTAINING DIETARY PHOSPHATE AND A HUMIC SUBSTANCE MUKHOPADHYAY, BHASKAR

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
16432
16551
17921
17311
16111
16161
16531

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18550728 USE OF A RED ALGA EXTRACT AS NEMATOSTATIC AND/OR NEMATICIDAL AGENT Agro Innovation International MELLER, MICHAEL V 1655 §103 Final Rejection Pending Sep 15, 2023
18333261 ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY Mcsaf Inside Oncology CANELLA, KAREN A 1643 DP Non-Final OA Pending Jun 12, 2023
18035224 RAW MATERIAL FOR ANIMAL NUTRITION COMPRISING AN ORGANO-MINERAL COMPLEX CONTAINING DIETARY PHOSPHATE AND A HUMIC SUBSTANCE Agro Innovation International MUKHOPADHYAY, BHASKAR 1792 §103 Final Rejection Pending May 03, 2023
18044169 OXIDATIVE METHOD FOR PREPARING A FERTILIZING COMPOSITION Ecole D'Ingenieurs De Purpan SMITH, JENNIFER A 1731 §112 Final Rejection 33d Pending Mar 06, 2023
18040468 HYDROGEL COMPRISING GLYCEROL AND A CARBOMER FOR TREATING THE RESPIRATORY SYMPTOMS OF COVID-19 DISEASE VIA THE NASAL ROUTE Cosmosoft LOVE, TREVOR M 1611 §103 Final Rejection 42d Pending Feb 03, 2023
17910934 PHYTOSANITARY COMPOSITION COMPRISING ULVANS AND SILICON Agro Innovation International SCHLIENTZ, NATHAN W 1616 §103 Final Rejection Pending Sep 12, 2022
17802274 ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY Mcsaf Inside Oncology CANELLA, KAREN A 1643 DP Final Rejection 53d overdue Pending Aug 25, 2022
17625440 TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD) UNIVERSITE D'EVRY VAL D'ESSONNE KOROTCHKINA, LIOUBOV G 1653 §103 Final Rejection 92d overdue Pending Jan 07, 2022

Managing Mh2 Technology Law Grp's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month